Ethic Inc’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.08M Sell
72,744
-5,275
-7% -$368K 0.09% 231
2025
Q1
$5.66M Sell
78,019
-19,589
-20% -$1.42M 0.11% 198
2024
Q4
$6.4M Buy
97,608
+6,475
+7% +$424K 0.13% 168
2024
Q3
$6.17M Sell
91,133
-16,607
-15% -$1.13M 0.16% 153
2024
Q2
$8.4M Buy
107,740
+16,607
+18% +$1.3M 0.2% 104
2024
Q1
$6.17M Buy
91,133
+4,158
+5% +$282K 0.16% 153
2023
Q4
$5.86M Buy
86,975
+8,394
+11% +$565K 0.17% 135
2023
Q3
$5.32M Buy
78,581
+3,428
+5% +$232K 0.19% 122
2023
Q2
$5.38M Buy
75,153
+791
+1% +$56.6K 0.2% 113
2023
Q1
$5.16M Sell
74,362
-4,834
-6% -$336K 0.21% 121
2022
Q4
$5.37M Buy
79,196
+11,358
+17% +$770K 0.29% 79
2022
Q3
$3.72M Sell
67,838
-3,844
-5% -$211K 0.25% 101
2022
Q2
$4.74M Buy
71,682
+8,263
+13% +$546K 0.33% 68
2022
Q1
$4.21M Buy
63,419
+25,070
+65% +$1.66M 0.29% 83
2021
Q4
$2.23M Sell
38,349
-579
-1% -$33.7K 0.17% 144
2021
Q3
$2.34M Buy
38,928
+12,370
+47% +$743K 0.24% 106
2021
Q2
$1.59M Buy
26,558
+6,113
+30% +$366K 0.19% 130
2021
Q1
$1.02M Buy
20,445
+2,332
+13% +$116K 0.18% 150
2020
Q4
$905K Buy
18,113
+3,555
+24% +$178K 0.24% 103
2020
Q3
$798K Buy
14,558
+2,026
+16% +$111K 0.31% 86
2020
Q2
$663K Buy
12,532
+2,443
+24% +$129K 0.38% 64
2020
Q1
$451K Buy
10,089
+2,112
+26% +$94.4K 0.38% 83
2019
Q4
$398K Buy
+7,977
New +$398K 0.29% 113